At 0 2 0 2 O
least 3 8 3 8 O
18 9 11 9 11 B-lower_bound
years 12 17 12 17 I-lower_bound
of 18 20 18 20 O
age 21 24 21 24 B-age

Female 0 6 25 31 B-gender

Pregnant 0 8 32 40 B-pregnancy

Prior 0 5 41 46 O
history 6 13 47 54 O
of 14 16 55 57 O
chest 17 22 58 63 B-treatment
wall 23 27 64 68 I-treatment
radiation 28 37 69 78 I-treatment

Scheduled 0 9 79 88 O
to 10 12 89 91 O
receive 13 20 92 99 O
neoadjuvant 21 32 100 111 B-treatment
chemotherapy 33 45 112 124 I-treatment
for 46 49 125 128 O
the 50 53 129 132 O
treatment 54 63 133 142 O
of 64 66 143 145 O
newly 67 72 146 151 O
diagnosed 73 82 152 161 O
, 82 83 161 162 O
locally 84 91 163 170 O
advanced 92 100 171 179 B-cancer
breast 101 107 180 186 I-cancer
cancer 108 114 187 193 I-cancer
or 115 117 194 196 O
scheduled 118 127 197 206 O
to 128 130 207 209 O
receive 131 138 210 217 O
neoadjuvant 139 150 218 229 B-treatment
endocrine 151 160 230 239 I-treatment
therapy 161 168 240 247 I-treatment
with 169 173 248 252 O
the 174 177 253 256 O
eventual 178 186 257 265 O
goal 187 191 266 270 O
of 192 194 271 273 O
surgery 195 202 274 281 B-treatment
of 203 205 282 284 O
newly 206 211 285 290 O
diagnosed 212 221 291 300 O
clinical 222 230 301 309 O
stage 231 236 310 315 B-cancer
II 237 239 316 318 I-cancer
- 239 240 318 319 I-cancer
III 240 243 319 322 I-cancer
ER+ 244 247 323 326 I-cancer
HER2- 248 253 327 332 I-cancer
breast 254 260 333 339 I-cancer
cancer 261 267 340 346 I-cancer
( 268 269 347 348 O
for 269 272 348 351 O
the 273 276 352 355 O
endocrine 277 286 356 365 O
therapy 287 294 366 373 O
cohort 295 301 374 380 O
) 301 302 380 381 O

